4.6 Article

Exploiting pre-rRNA processing in Diamond Blackfan anemia gene discovery and diagnosis

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 89, Issue 10, Pages 985-991

Publisher

WILEY
DOI: 10.1002/ajh.23807

Keywords

-

Categories

Funding

  1. Diamond Blackfan Anemia Foundation
  2. Arkansas Biosciences Institute
  3. Cariplo [2011-0554]
  4. Feinstein Institute for Medical Research General Research Center [M01 RR018535]
  5. Istituto Piemontese per la ricerca sulla Anemia di Diamond-Blackfan
  6. National Institutes of Health [K08 HL092224, R109 MOHLKE, R01 HL07957]
  7. National Human Genome Research Institute Intramural Funds
  8. Pediatric Cancer Foundation
  9. PRIN
  10. Telethon [GGP13177]

Ask authors/readers for more resources

Diamond Blackfan anemia (DBA), a syndrome primarily characterized by anemia and physical abnormalities, is one among a group of related inherited bone marrow failure syndromes (IBMFS) which share overlapping clinical features. Heterozygous mutations or single-copy deletions have been identified in 12 ribosomal protein genes in approximately 60% of DBA cases, with the genetic etiology unexplained in most remaining patients. Unlike many IBMFS, for which functional screening assays complement clinical and genetic findings, suspected DBA in the absence of typical alterations of the known genes must frequently be diagnosed after exclusion of other IBMFS. We report here a novel deletion in a child that presented such a diagnostic challenge and prompted development of a novel functional assay that can assist in the diagnosis of a significant fraction of patients with DBA. The ribosomal proteins affected in DBA are required for pre-rRNA processing, a process which can be interrogated to monitor steps in the maturation of 40S and 60S ribosomal subunits. In contrast to prior methods used to assess pre-rRNA processing, the assay reported here, based on capillary electrophoresis measurement of the maturation of rRNA in pre-60S ribosomal subunits, would be readily amenable to use in diagnostic laboratories. In addition to utility as a diagnostic tool, we applied this technique to gene discovery in DBA, resulting in the identification of RPL31 as a novel DBA gene. Am. J. Hematol. 89:985-991, 2014. (c) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available